John Iskander

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. pmc Pandemic influenza planning, United States, 1978-2008
    John Iskander
    Office of the Associate Director, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop D50, Atlanta, GA 30333, USA
    Emerg Infect Dis 19:879-85. 2013
  2. doi request reprint Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience
    John Iskander
    US Public Health Service, Immunization Safety Office, Office of Chief Science Officer, Centers for Disease Control and Prevention, 1600 Clifton Road, MS D 26, Atlanta, GA 30333, USA
    Expert Rev Vaccines 7:75-82. 2008
  3. ncbi request reprint Data mining in the US using the Vaccine Adverse Event Reporting System
    John Iskander
    Office of Immunization Safety, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Drug Saf 29:375-84. 2006
  4. pmc Monitoring vaccine safety during an influenza pandemic
    John Iskander
    Immunization Safety Office, Office of the Chief Science Officer, Office of the Director, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Yale J Biol Med 78:265-75. 2005
  5. pmc Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study
    Lisa A Jackson
    Group Health Research Institute, Seattle WA, USA
    BMC Infect Dis 9:165. 2009
  6. doi request reprint Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003
    Juliette Morgan
    Centers for Disease Control and Prevention and 2Department of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA
    Clin Infect Dis 46:S242-50. 2008
  7. doi request reprint Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safety
    Penina Haber
    Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mail Stop D 26, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Pediatrics 127:S39-44. 2011
  8. doi request reprint Death and serious illness following influenza vaccination: a multidisciplinary investigation
    Alison Rue-Cover
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Immunization Safety Office ISO, Division of Healthcare Quality Promotion, Atlanta, GA 30333, USA
    Pharmacoepidemiol Drug Saf 18:504-11. 2009
  9. doi request reprint Tracking vaccine-safety inquiries to detect signals and monitor public concerns
    Elaine Miller
    Division of Healthcare Quality Promotion, Immunization Safety Office, Centers for Disease Control and Prevention, Mail Stop D 26, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Pediatrics 127:S87-91. 2011
  10. ncbi request reprint How can you promote vaccine safety?
    Elaine R Miller
    Immunization Safety Office, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Nursing 37:58-63; quiz 63-4. 2007

Collaborators

Detail Information

Publications18

  1. pmc Pandemic influenza planning, United States, 1978-2008
    John Iskander
    Office of the Associate Director, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop D50, Atlanta, GA 30333, USA
    Emerg Infect Dis 19:879-85. 2013
    ..Preparedness planning will enhance the collective, multilevel response to future public health crises...
  2. doi request reprint Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience
    John Iskander
    US Public Health Service, Immunization Safety Office, Office of Chief Science Officer, Centers for Disease Control and Prevention, 1600 Clifton Road, MS D 26, Atlanta, GA 30333, USA
    Expert Rev Vaccines 7:75-82. 2008
    ..Thus, the challenge of influenza vaccine safety is to detect new safety concerns that may arise during seasonal campaigns, while preparing vaccine safety systems for the timely detection of adverse events in the setting of a pandemic...
  3. ncbi request reprint Data mining in the US using the Vaccine Adverse Event Reporting System
    John Iskander
    Office of Immunization Safety, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Drug Saf 29:375-84. 2006
    ..Such approaches are needed as more new vaccines continue to be licensed...
  4. pmc Monitoring vaccine safety during an influenza pandemic
    John Iskander
    Immunization Safety Office, Office of the Chief Science Officer, Office of the Director, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Yale J Biol Med 78:265-75. 2005
    ..Advance planning and the use of available technologic solutions are needed to respond to the scientific and logistic challenges involved in safely implementing mass vaccination during a pandemic...
  5. pmc Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study
    Lisa A Jackson
    Group Health Research Institute, Seattle WA, USA
    BMC Infect Dis 9:165. 2009
    ..Local reactions are the most commonly reported adverse events following tetanus and diphtheria toxoid (Td) vaccine and the risk of local reactions may increase with number of prior Td vaccinations...
  6. doi request reprint Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003
    Juliette Morgan
    Centers for Disease Control and Prevention and 2Department of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA
    Clin Infect Dis 46:S242-50. 2008
    ..We describe an association between smallpox vaccination, using the US vaccinia strain, and myo/pericarditis among civilians...
  7. doi request reprint Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safety
    Penina Haber
    Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mail Stop D 26, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Pediatrics 127:S39-44. 2011
    ....
  8. doi request reprint Death and serious illness following influenza vaccination: a multidisciplinary investigation
    Alison Rue-Cover
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Immunization Safety Office ISO, Division of Healthcare Quality Promotion, Atlanta, GA 30333, USA
    Pharmacoepidemiol Drug Saf 18:504-11. 2009
    ..All had received vaccine from the same lot (Lot A)...
  9. doi request reprint Tracking vaccine-safety inquiries to detect signals and monitor public concerns
    Elaine Miller
    Division of Healthcare Quality Promotion, Immunization Safety Office, Centers for Disease Control and Prevention, Mail Stop D 26, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Pediatrics 127:S87-91. 2011
    ..Past inquiries to public health authorities identified potential problems including viscerotropic illness rarely associated with yellow fever vaccination...
  10. ncbi request reprint How can you promote vaccine safety?
    Elaine R Miller
    Immunization Safety Office, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Nursing 37:58-63; quiz 63-4. 2007
  11. ncbi request reprint Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS)
    Lauren DiMiceli
    Immunization Safety Branch, NIP CDC, Mail Stop E61, Atlanta, GA 30333, USA
    Vaccine 24:703-7. 2006
    ..Nevertheless, yeast associated anaphylaxis after HBV in sensitized patients appears to be a rare event...
  12. doi request reprint Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine
    Barbara A Slade
    Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop D 26, Atlanta, GA 30333, USA
    JAMA 302:750-7. 2009
    ....
  13. ncbi request reprint Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004
    James J Sejvar
    Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 294:2744-50. 2005
    ..The reinstatement of smallpox vaccination in the United States in response to possible bioterrorism renewed concerns about vaccine-related adverse neurologic events...
  14. ncbi request reprint Guillain-Barré syndrome following influenza vaccination
    Penina Haber
    Immunization Safety Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 292:2478-81. 2004
    ..Guillain-Barre syndrome remains the most frequent neurological condition reported after influenza vaccination to the Vaccine Adverse Events Reporting System (VAERS) since its inception in 1990...
  15. doi request reprint Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007
    Penina Haber
    Centers for Disease Control and Prevention, National Center for Immunizations and Respiratory Diseases, 1600 Clifton Rd, MS A 47, Atlanta, GA 30333, USA
    Pediatrics 121:1206-12. 2008
    ..Although the new rotavirus vaccine (RotaTeq; Merck, West Point, PA) introduced in 2006 was not associated with intussusception in prelicensure trials, additional monitoring is important to ensure a complete safety profile...
  16. ncbi request reprint Tracking vaccine lot lifecycles using reports to the vaccine adverse event reporting system (VAERS)
    Gustavo H Dayan
    Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pharmacoepidemiol Drug Saf 14:671-6. 2005
    ..We used data from reports to the Vaccine Adverse Event Reporting System (VAERS) to develop a proxy means of surveillance for the lifecycle of selected vaccine lots...
  17. doi request reprint A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data
    Jane Gidudu
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Vaccine 26:6800-13. 2008
    ....
  18. doi request reprint Ischemic cardiac events during the Department of Health and Human Services Smallpox Vaccination Program, 2003
    David L Swerdlow
    Smallpox Vaccine Adverse Events Monitoring and Response Activity, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 46:S234-41. 2008
    ..10; 95% PI, 3.5-15.7). After persons with >/=3 cardiac risk factors or known heart disease were deferred from vaccination, no ICEs were reported among an additional 6638 vaccinees...